Akers Biosciences CEO Christopher Schreiber's 2020 pay jumps 1,909% to $1.1M
Akers Biosciences reports 2020 executive compensation
By ExecPay News
Published: October 26, 2022
Akers Biosciences reported fiscal year 2020 executive compensation information on October 26, 2022.
In 2020, five executives at Akers Biosciences received on average a compensation package of $434K, a 121% increase compared to previous year.
Christopher C. Schreiber, Chief Executive Officer, received $1.1M in total, which increased by 1,909% compared to 2019. 54% of Schreiber's compensation, or $590K, was in stock awards. Schreiber also received $150K in bonus, $300K in salary, as well as $58K in other compensation.
Adam Kaplin, Chief Scientific Officer, received a compensation package of $361K. 67% of the compensation package, or $240K, was in option awards.
Christopher Chapman, Chief Medical Officer, earned $298K in 2020.
Howard R. Yeaton, Chief Executive Officer, received $240K in 2020, which decreases by 29% compared to 2019.
Paul Rivard, General Counsel, earned $175K in 2020.